Basic information Safety Supplier Related

Bardoxolone

Basic information Safety Supplier Related

Bardoxolone Basic information

Product Name:
Bardoxolone
Synonyms:
  • 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid
  • CDDO(Bardoxolone)
  • BARDOXOLONE;CDDO;RTA 401
  • Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-
  • Bardoxolone
  • CDDO
  • RTA 401
  • 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid
CAS:
218600-44-3
MF:
C31H41NO4
MW:
491.66
Mol File:
218600-44-3.mol
More
Less

Bardoxolone Chemical Properties

Melting point:
180-182 °C
Boiling point:
632.9±55.0 °C(Predicted)
Density 
1.18
storage temp. 
Sealed in dry,Store in freezer, under -20°C
solubility 
≥49.2 mg/mL in DMSO; insoluble in H2O; ≥2.682 mg/mL in EtOH with gentle warming and ultrasonic
form 
solid
pka
4.52±0.70(Predicted)
color 
White to yellow
More
Less

Bardoxolone Usage And Synthesis

Chemical Properties

Tan Solid

Uses

Bardoxolone is a synthetic oleanane triterpenoid that exerts multifunctional activities in the control of cellular growth and differentiation. Bardoxolone is capable of activating the transcription fa ctor peroxisome proliferator activator receptor-γ (PPARγ), its apoptotic effects in malignant cells have been shown to occur independently of PPARγ. Bardoxolone was developed as an potential drug for the improvement of hyperglycemia, proteinuria, glomerulus structure, serum creatine, which may in turn be beneficial to treat diabetic kidney diseases, cancer and thromboembolic events.

Definition

ChEBI: Bardoxolone is a member of cyclohexenones.

Biological Activity

bardoxolone methyl, previously known as rta 402, is the lead molecule in reata's portfolio of antioxidant inflammation modulators (aims). the aims are potent inducers of the transcription factor nrf2, an important biological target that controls the production of many of the body's antioxidant and detoxification enzymes. because oxidative stress and inflammation occur throughout the course of chronic kidney disease (ckd) and are known to contribute to loss of kidney function, agents that activate the nrf2 pathway in patients with ckd may provide a novel method for preserving or improving kidney function. bardoxolone methyl is currently being investigated as a potential oral once-a-day treatment for ckd.

BardoxoloneSupplier

Shanghai Mawei Biological Technology Co., LTD Gold
Tel
13671830408
Email
maievbiotech@163.com
ShangHai Caerulum Pharma Discovery Co., Ltd. Gold
Tel
18149758185 18149758185
Email
sales-cpd@caerulumpharma.com
Shanghai Jingjinchem Co., Ltd. Gold
Tel
021-13817626287 13817626287
Email
1094777898@qq.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
More
Less

Bardoxolone(218600-44-3)Related Product Information